Does ASCIMINIB Cause Malignant neoplasm progression? 67 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 67 reports of Malignant neoplasm progression have been filed in association with ASCIMINIB (SCEMBLIX). This represents 2.9% of all adverse event reports for ASCIMINIB.
67
Reports of Malignant neoplasm progression with ASCIMINIB
2.9%
of all ASCIMINIB reports
30
Deaths
16
Hospitalizations
How Dangerous Is Malignant neoplasm progression From ASCIMINIB?
Of the 67 reports, 30 (44.8%) resulted in death, 16 (23.9%) required hospitalization, and 5 (7.5%) were considered life-threatening.
Is Malignant neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ASCIMINIB. However, 67 reports have been filed with the FAERS database.
What Other Side Effects Does ASCIMINIB Cause?
Fatigue (193)
Death (144)
Nausea (138)
Thrombocytopenia (125)
Drug ineffective (117)
Diarrhoea (103)
Drug intolerance (98)
Headache (91)
Rash (86)
Pleural effusion (75)
What Other Drugs Cause Malignant neoplasm progression?
PEMBROLIZUMAB (10,111)
NIVOLUMAB (9,363)
ENZALUTAMIDE (4,696)
CARBOPLATIN (4,177)
EVEROLIMUS (3,789)
PACLITAXEL (3,484)
LETROZOLE (3,445)
IPILIMUMAB (3,296)
FULVESTRANT (3,221)
LENVATINIB (2,929)
Which ASCIMINIB Alternatives Have Lower Malignant neoplasm progression Risk?
ASCIMINIB vs ASCORBIC ACID
ASCIMINIB vs ASCORBIC ACID\FERROUS
ASCIMINIB vs ASCORBIC ACID\FERROUS\FOLIC ACID
ASCIMINIB vs ASCORBIC ACID\POLYETHYLENE GLYCOL 3350\POTASSIUM\SODIUM ASCORBATE\SODIUM\SODIUM
ASCIMINIB vs ASENAPINE